Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2012
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157372 Human milk peptides
06/21/2012US20120156786 Ready-to-use electroporation cuvette including frozen electrocompetent cells
06/21/2012US20120156785 Methods and products for biasing cellular development
06/21/2012US20120156771 Functional disruption of an immunoglobulin gene in an avian embryonic stem cell
06/21/2012US20120156770 Human androgen receptor alternative splice variants
06/21/2012US20120156755 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
06/21/2012US20120156754 Variant cbh2 cellulases and related polynucleotides
06/21/2012US20120156745 Methyl butenol synthase
06/21/2012US20120156735 Recombinant host cells comprising phosphoketolases
06/21/2012US20120156734 Thermostable paenibacillus xylanases
06/21/2012US20120156732 Useful polypeptides
06/21/2012US20120156729 Selective terminal tagging of nucleic acids
06/21/2012US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
06/21/2012US20120156724 Humanized anti-cd47 antibody
06/21/2012US20120156722 Tumor Suppressor Gene
06/21/2012US20120156720 Compositions and Methods of Producing Enterokinase in Yeast
06/21/2012US20120156718 Production of Ketocarotenoids in Plants
06/21/2012US20120156705 luciferases and uses thereof
06/21/2012US20120156695 Microorganism for expressing a human membrane protein
06/21/2012US20120156694 Proteins used for the diagnosis of lyme borreliosis
06/21/2012US20120156673 Methods for agrobacterium-mediated transformation of sugar cane
06/21/2012US20120156672 Novel stringent selectable markers
06/21/2012US20120156360 Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
06/21/2012US20120156329 Expression Of Granular Starch Hydrolyzing Enzymes In Trichoderma And Process For Producing Glucose From Granular Starch Substrates
06/21/2012US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
06/21/2012US20120156254 Recombinant laminin-521
06/21/2012US20120156249 Genetically modified organism for the production of lipids
06/21/2012US20120156241 Rescue of influenza virus
06/21/2012US20120156239 Optimized vaccines to provide protection against ebola and other viruses
06/21/2012US20120156238 Herpes virus backbone for viral vaccine and vaccine based thereon
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156233 Vaccine therapy for choroidal neovascularization
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156223 Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156217 Novel EGFR-Binding Molecules and Immunoconjugates Thereof
06/21/2012US20120156208 Therapeutic uses of inhibitors of rtp801
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156195 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
06/21/2012US20120156186 Non-cytotoxic protein conjugates
06/21/2012US20120156173 Fusarium and other pathogenic fungi and mycotoxin biocontrol
06/21/2012US20120156169 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
06/21/2012US20120156162 Perhydrolase variant providing improved specific activity
06/21/2012US20120156161 Perhydrolase variant providing improved specific activity
06/21/2012US20120156160 Perhydrolase variant providing improved specific activity
06/21/2012US20120156159 Perhydrolase variant providing improved specific activity
06/21/2012US20120156158 Perhydrolase variant providing improved specific activity
06/21/2012US20120156157 Perhydrolase variant providing improved specific activity
06/21/2012US20120156156 Perhydrolase variant providing improved specific activity
06/21/2012US20120156155 Perhydrolase variant providing improved specific activity
06/21/2012US20120152818 Method and Device for Purifying Nucleic Acids
06/21/2012US20120151833 Lipid Production
06/21/2012DE112010003493T5 Regulatorische Nukleinsäuremoleküle für die Verstärkung der samenspeziflschen und/oder samenpräferentielen Genexpression in Pflanzen Regulatory nucleic acid molecules for the amplification of the samenspeziflschen and / or gene expression in plants samenpräferentielen
06/21/2012DE112009002577T5 Pflanzen mit erhöhtem Ertrag (NUE) Plants having increased yield (NUE)
06/21/2012DE102011006610B3 Aptamere, die spezifisch sind für Immunoglobulin bindende Zellwandproteine Aptamers that are specific for immunoglobulin binding cell wall proteins
06/21/2012CA2821952A1 Melanoma treatments
06/21/2012CA2821888A1 Method for producing proteins
06/21/2012CA2821519A1 Combined use of vip3ab and cry1ab for management of resistant insects
06/21/2012CA2821268A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
06/21/2012CA2821101A1 Soybean event syht0h2 and compositions and methods for detection thereof
06/21/2012CA2820440A1 The abcg1 gene as a marker and a target gene for treating obesity
06/21/2012CA2820151A1 Process for production of protein
06/21/2012CA2818917A1 Plants having increased tolerance to herbicides
06/21/2012CA2816495A1 Insulin producing cells derived from pluripotent stem cells
06/21/2012CA2816155A1 Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
06/21/2012CA2815286A1 Cry1i proteins and genes for insect control
06/20/2012EP2465946A2 Method for screening and quantifying various enzyme activities using a genetic enzyme screening system
06/20/2012EP2465935A2 Recombinant human interferon-like proteins
06/20/2012EP2465934A1 Extraction of nucleic acids
06/20/2012EP2465933A2 Disease-inducible promoters
06/20/2012EP2465932A2 Organ-specific gene, method for identifying the same and use thereof
06/20/2012EP2465931A1 Light-receiving channel rhodopsin having improved expression efficiency
06/20/2012EP2465930A2 Amylase variants
06/20/2012EP2465928A1 Treatment of Th17-mediated diseases
06/20/2012EP2465870A1 Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
06/20/2012EP2465530A1 Multivalent entrain-and-amplify immunotherapeutics for carcinoma
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2465343A1 Cultivated plant having tobacco streak virus resistance
06/20/2012EP2465342A1 Slow-maturing, determinate peas
06/20/2012EP2465341A1 EPSPS Mutants
06/20/2012EP2465340A1 EPSPS mutants
06/20/2012EP2464755A2 Methods and kits for 3'-end-tagging of rna
06/20/2012EP2464751A2 Methods, primers, probes and kits useful for the detection of braf mutations
06/20/2012EP2464750A1 Organisms homozygous for targeted modification
06/20/2012EP2464749A1 Cdc45l as tumor marker and therapeutic target for cancer
06/20/2012EP2464739A2 Methods in cell cultures, and related inventions, employing certain additives
06/20/2012EP2464733A1 Stress tolerant plants
06/20/2012EP2464732A1 Fermentation process
06/20/2012EP2464731A2 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
06/20/2012EP2464730A1 miRNA COMPOUNDS FOR TREATMENT OF PROSTATE CARCINOMA
06/20/2012EP2464729A2 METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES
06/20/2012EP2464728A1 A rational library
06/20/2012EP2464727A2 Peptide libraries
06/20/2012EP2464664A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
06/20/2012EP2464663A2 Engineered proteins including mutant fibronectin domains
06/20/2012EP2464658A1 Detoxified escherichia coli immunogens
06/20/2012EP2464385A2 Photochemical internalization method
06/20/2012EP2464384A2 Photosensitizing compositions
06/20/2012EP2464336A2 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus